不依赖厂商的冠状动脉钙化评分改善个体风险评估:MESA(多种族动脉粥样硬化研究)
研究用7种CT和1种电子束体层摄影系统对2个含钙体模成像,推导出可计算不依赖厂商Agatston评分(vnAS)的校准工具;在MESA的3,181名参与者中分析vnAS对冠心病事件预测的影响,结果显示原低钙组中85名(11%)被重新分入更高风险类别,其冠心病事件率15%显著高于原低钙组的7%(P=0.008),冠心病HR为3.39(95%CI:1.82-6.35;P=0.001),提示风险分类得到改善。
要点
- 不同CT扫描仪测得的Agatston评分存在较大差异,可能影响患者风险分类。
- 校准工具使各CT系统与电子束体层摄影的Agatston评分强相关(R²>0.932)。
- 原低钙组中11%被vnAS重新分入更高风险类别,其冠心病事件率更高。
核心结论
- 作者开发了可计算vnAS的校准工具;MESA中被vnAS重新分入更高钙化类别的参与者发生更多冠心病事件,提示风险分类得到改善。
研究设计与样本
- 研究对2个含钙体模在7种不同CT和1种电子束体层摄影系统(作为参考系统)上成像以推导vnAS校准工具,并用MESA的3,181名参与者数据分析vnAS对冠心病事件预测的影响,采用卡方分析比较低钙组(vnAS<100)与高钙组(vnAS≥100)的冠心病事件率,采用多变量Cox比例风险回归模型评估vnAS的增量价值。
诊断标准与关键数值
- 低钙组定义为vnAS<100,高钙组定义为vnAS≥100。
- 所有CT系统与电子束体层摄影Agatston评分呈强相关(R²>0.932)。
- 原低钙组(n=781)中85名(11%)参与者基于重新计算的vnAS被重新分入更高风险类别。
- 被重新分类参与者的冠心病事件率为15%,显著高于低钙组参与者的7%(P=0.008)。
- 被重新分类参与者的冠心病HR为3.39(95%CI:1.82-6.35;P=0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Substantial variation in Agatston scores (AS) acquired with different computed tomography (CT) scanners may influence patient risk classification.
OBJECTIVES: This study sought to develop a calibration tool for state-of-the-art CT systems resulting in vendor-neutral AS (vnAS), and to assess the impact of vnAS on coronary heart disease (CHD) event prediction.
METHODS: The vnAS calibration tool was derived by imaging 2 anthropomorphic calcium containing phantoms on 7 different CT and 1 electron beam tomography system, which was used as the reference system. The effect of vnAS on CHD event prediction was analyzed with data from 3,181 participants from MESA (Multi-Ethnic Study on Atherosclerosis). Chi-square analysis was used to compare CHD event rates between low (vnAS <100) and high calcium groups (vnAS ≥100). Multivariable Cox proportional hazard regression models were used to assess the incremental value of vnAS.
RESULTS: For all CT systems, a strong correlation with electron beam tomography-AS was found (R2 >0.932). Of the MESA participants originally in the low calcium group (n = 781), 85 (11%) participants were reclassified to a higher risk category based on the recalculated vnAS. For reclassified participants, the CHD event rate of 15% was significantly higher compared with participants in the low calcium group (7%; P = 0.008) with a CHD HR of 3.39 (95% CI: 1.82-6.35; P = 0.001).
CONCLUSIONS: The authors developed a calibration tool that enables calculation of a vnAS. MESA participants who were reclassified to a higher calcium category by means of the vnAS experienced more CHD events, indicating improved risk categorization.
引用
- van der Werf, Dobrolinska, Greuter, et al. Vendor Independent Coronary Calcium Scoring Improves Individual Risk Assessment: MESA (Multi-Ethnic Study of Atherosclerosis). JACC Cardiovasc Imaging. 2023. PMID: 37318394. doi:10.1016/j.jcmg.2023.05.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。